Lindhout; Darrin Anthony

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lindhout; Darrin Anthony.The latest application filed is for "methods of using compositions comprising variants and fusions of fgf19 polypeptides for treatment of metabolic disorders and diseases".

Company Profile

13.24.32

Lindhout; Darrin Anthony - Mountain View CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods of use for treating metabolic disorders Grant 11,358,995 - Lindhout , et al. June 14, 2	2022-06-14
Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and Diseases App 20220088140 - Ling; Lei ; et al.	2022-03-24
Pharmaceutical Compositions Comprising Peptide Variants And Methods Of Use Thereof App 20220047675 - Lindhout; Darrin Anthony ; et al.	2022-02-17
Compositions and Methods of Use for Treating Metabolic Disorders App 20210388047 - Matern; Hugo ; et al.	2021-12-16
Compositions comprising variants and fusions of FGF19 polypeptides Grant 11,066,454 - Ling , et al. July 20, 2	2021-07-20
Compositions comprising fusion variants of FGF19 polypeptides Grant 11,065,302 - Ling , et al. July 20, 2	2021-07-20
Compositions and Methods for Treatment of Metabolic Disorders and Diseases App 20210169983 - Ling; Lei ; et al.	2021-06-10
Compositions and methods of use for treating metabolic disorders Grant 10,869,909 - Lindhout , et al. December 22, 2	2020-12-22
Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes Grant 10,758,590 - Ling , et al. Sep	2020-09-01
Pharmaceutical Compositions Comprising Peptide Variants And Methods Of Use Thereof App 20200197490 - Lindhout; Darrin Anthony ; et al.	2020-06-25
Compositions and Methods of Use for Treating Metabolic Disorders App 20200165314 - Lindhout; Darrin Anthony ; et al.	2020-05-28
Compositions and Methods of Use for Treating Metabolic Disorders App 20200140536 - Shen; Wenyan ; et al.	2020-05-07
Compositions and methods of use for treating metabolic disorders Grant 10,610,568 - Matern , et al.	2020-04-07
Compositions and Methods of Use For Treating Metabolic Disorders App 20200087366 - Matern; Hugo ; et al.	2020-03-19
Methods and Compositions for the Treatment of Metabolic Disorders and Diseases App 20200054714 - Ling; Lei ; et al.	2020-02-20
Compositions and methods of use for treating metabolic disorders Grant 10,562,965 - Shen , et al. Feb	2020-02-18
Pharmaceutical compositions comprising FGF19 variants Grant 10,517,929 - Lindhout , et al. Dec	2019-12-31
Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject Grant 10,413,590 - Ling , et al. Sept	2019-09-17
Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions Grant 10,398,758 - Ling , et al. Sep	2019-09-03
Compositions and Methods of Use for Treating Metabolic Disorders App 20190183974 - Lindhout; Darrin Anthony ; et al.	2019-06-20
Compositions and methods of use for treating metabolic disorders Grant 10,323,075 - Matern , et al.	2019-06-18
Compositions Comprising Variants And Fusions Of Fgf19 Polypeptides App 20190177384 - Ling; Lei ; et al.	2019-06-13
Compositions and methods of use for treating metabolic disorders Grant 10,195,250 - Lindhout , et al. Fe	2019-02-05
Compositions Comprising Variants and Fusions of FGF19 Polypeptides App 20180355007 - Ling; Lei ; et al.	2018-12-13
Compositions and Methods of Use for Treating Metabolic Disorders App 20180237514 - Shen; Wenyan ; et al.	2018-08-23
Compositions and Methods of Use for Treating Metabolic Disorders App 20180134761 - Lindhout; Darrin Anthony ; et al.	2018-05-17
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject Grant 9,963,494 - Ling , et al. May 8, 2	2018-05-08
Compositions and methods of use for treating metabolic disorders App 20180099025 - Matern; Hugo ; et al.	2018-04-12
Compositions and Methods of Use For Treating Metabolic Disorders App 20180100003 - Matern; Hugo ; et al.	2018-04-12
Compositions and methods of use for treating metabolic disorders Grant 9,920,118 - Shen , et al. March 20, 2	2018-03-20
Compositions and methods of use for treating metabolic disorders Grant 9,834,586 - Lindhout , et al. December 5, 2	2017-12-05
Compositions and methods of use for treating metabolic disorders Grant 9,828,415 - Matern , et al. November 28, 2	2017-11-28
Compositions and methods of use for treating metabolic disorders Grant 9,827,291 - Matern , et al. November 28, 2	2017-11-28
Methods Of Using Compositions Comprising Fusion Variants Of Fgf19 Polypeptides For Reducing Glucose Levels In A Subject App 20170327551 - LING; Lei ; et al.	2017-11-16
Methods of using compositions comprising fusion variants of FGF19 polypeptides for reducing glucose levels in a subject Grant 9,751,924 - Ling , et al. September 5, 2	2017-09-05
Compositions and Methods of Use for Treating Metabolic Disorders App 20170246249 - Lindhout; Darrin Anthony ; et al.	2017-08-31
Pharmaceutical Compositions Comprising Peptide Variants And Methods Of Use Thereof App 20170232067 - LINDHOUT; Darrin Anthony ; et al.	2017-08-17
Methods And Compositions For The Treatment Of Metabolic Disorders And Diseases App 20170182122 - LING; Lei ; et al.	2017-06-29
Compositions comprising fusion variants of FGF19 polypeptides Grant 9,670,260 - Ling , et al. June 6, 2	2017-06-06
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of diabetes Grant 9,580,483 - Ling , et al. February 28, 2	2017-02-28
Compositions and methods of use for treating metabolic disorders Grant 9,550,819 - Lindhout , et al. January 24, 2	2017-01-24
Compositions, Uses And Methods For Treatment Of Metabolic Disorders And Diseases App 20160200788 - Ling; Lei ; et al.	2016-07-14
Compositions And Methods Of Use For Treating Metabolic Disorders App 20160200787 - Matern; Hugo ; et al.	2016-07-14
Compositions Comprising Variants And Fusions Of Fgf19 Polypeptides App 20160168215 - Ling; Lei ; et al.	2016-06-16
Methods Of Using Compositions Comprising Variants And Fusions Of Fgf19 Polypeptides For Reducing Glucose Levels In A Subject App 20160168216 - Ling; Lei ; et al.	2016-06-16
Compositions And Methods Of Use For Treating Metabolic Disorders App 20160129082 - Matern; Hugo ; et al.	2016-05-12
Compositions And Methods Of Use For Treating Metabolic Disorders App 20160120999 - Shen; Wenyan ; et al.	2016-05-05
Compositions comprising variants and fusions of FGF19 polypeptides Grant 9,290,557 - Ling , et al. March 22, 2	2016-03-22
Compositions And Methods Of Use For Treating Metabolic Disorders App 20160031960 - Lindhout; Darrin Anthony ; et al.	2016-02-04
GDF15 mutein polypeptides Grant 9,161,966 - Matern , et al. October 20, 2	2015-10-20
Compositions And Methods For Treatment Of Metabolic Disorders And Diseases App 20150291677 - Ling; Lei ; et al.	2015-10-15
Methods Of Using Compositions Comprising Variants And Fusions Of Fgf19 Polypeptides For Treatment Of Metabolic Disorders And Diseases App 20150284442 - LING; Lei ; et al.	2015-10-08
Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject Grant 9,089,525 - Ling , et al. July 28, 2	2015-07-28
Compositions and Methods of Use for Treating Metabolic Disorders App 20150023960 - Lindhout; Darrin Anthony ; et al.	2015-01-22
Compositions And Methods Of Use For Treating Metabolic Disorders App 20140213511 - Matern; Hugo ; et al.	2014-07-31
Compositions and Methods for Treatment of Metabolic Disorders and Diseases App 20140194352 - Ling; Lei ; et al.	2014-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.